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     The incidence and occurrence of Mycoplasma pneumoniae (=M. pneu.) pneumonia 
in patients who visited Nagasaki University Hospital were investigated during the 15-year 
period from 1968 to 1982. 
     A total of 2754 selected patients with acute respiratory tract infection, including 
clinically primary atypical pneumonia (=PAP) (642 cases) were studied. Of these, 241 
cases (37.5%) had M. pneu. pneumonia as diagnosed on the basis of four-fold or greater 
rises in specific antibody titers against M. pneu. for a titer of 1:64. 
     Outbreaks occurred during 3-5 year periods including 1971-1972, 1975-1976, and 
1980. Most cases were seen in April, May and August showing seasonal peaks in 
spring and early autumn. 
     This incidence and occurrence of M. pneu. pneumonia in Nagasaki City and sur-
rounding suburbs were compared to those reported in Norway, Finland, Denmark, United 
Kingdom, the Netherlands and various cities in both the United States and Japan. 
-Mycoplasma; Mycoplasma pneumoniae infection; Epidemiology .
                  INTRODUCTION 
     M. pneu. pneumonia occurs throughout the world. Longitudinal studies indicate 
that the disease occurs throughout the year, as do most respiratory disease that peak 
during the colder months. Although there has been seasonal outbreaks o f M. pneu. 
pneumonia were reported in various parts of the world, the degree of communicability 
appears to be far less than that seen with common respiratory viruses. 
     Studies have shown that the degree of spread is directly related to the small com-
munity as well as military, dormitory facilities, schools and kindergartens. Studies have
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also that the presence of susceptible children is an important indicator in the transmission 
of disease throughout the family. 
      The incidence and occurrence of M. pneu. infection have been reported in Nor-
way, Finland, Denmark, United Kingdom, the Netherlands and in various cities in 
Japan and the United States2)3)s)-17)19)-33) Outbreaks generally occur in densely popu-
lated areas and under conditions in which subjects are confined to enclosed areas such 
as military and university housing. 
     Cyclic patterns of outbreaks general occur within 3-5 year periods. 
      The purpose of the present study to establish the incidence and occurrence of M. 
pneu. pneumonia in Nagasaki City and the surrounding areas, and to compare those 
findings with the incidence reported in other part of the world. 
              MATERIAL AND METHODS 
     Patients : Patients with acute respiratory disease including 642 cases with PAP were 
examined at the 2nd Department of Internal Medicine, Nagasaki University School of 
Medicine, Nagasaki Municipal Hospital and Fukui Hospital in Nagasaki City for the 
presence of M. pneu. infection. A total of 2754 patients were examined during a 15-
year period from 1968 through 1982. 
     Diagnosis : The diagnosis of M. pneu. infection was made on the basis of micro-
biological (isolation of M. pneu. ), serological methods (complement fixation test, cold 
hemoagglutinin test), clinical signs and symptoms and chest X-ray. 
     Mycoplasma cultural techniques : Nasopharyngeal swabs, nasopharyngeal washings 
or sputum specimens were inoculated directly onto PPLO agar and into PPLO broth 
media on the day of collection. One broth medium tube and two agar plates were used 
for each specimen. All cultures were incubated at 37°C. The agar plates were observed 
periodically for development of typical colonies. The identification of M. pneu. was 
determined by the paper disc diffusion method described by CLYDE4) . The broth cul-
tures were subcultured to the agar plate following the first signs of growth and at weekly 
intervals for two to four weeks. 
     Complement-fixation test : Antigen was made with the FH strain of M. pneu.. 
The procedure used here was essentially that the same with the procedure reported by 
KENNY and co-worker's18). Blood was obtained at the first visit and generally 2 weeks 
later for preparation of serum to determined CF antibody titers specific for M. pneu. 
infection. In addition, sera were tested for cold agglutinin titers. Evidence of M. 
pneu. pneumonia was based on specific CF antibody titers of 1:64, or a four-fold or 
greater rise in antibody titers between the acute and convalescent sera. 
     Clinical signs and symptoms: All patients were clinically examined for signs and 
symptoms of cough, sputum, sore throat, nasal discomfort, chest pain, headache, ar-
thralgia, earache and also rales in chest. 
     Chest X ray : Front and lateral chest X-ray taken at the time of initial examination
were classified according to the location, area and characteristic of shadows by discussion 
with four specialists of the respiratory diseases. 
                     RESULTS
      Six hundread forty two patients with PAP were examined during a 15-year period. 
Of these, 241 cases (37.5%) were diagnosed as M. pneu. pneumonia. 
     1) Age and sex (Table 1) : Age ranged from 10 months to 84 years. Thirty-five 
cases (14.5%) were aged 9 years or less, 43 cases (17.8%) 10 to 19 years, 51 cases (21 .2 
%) 20 to 29 years, and 55 cases (22.8%) 30 to 39 years. Approximately three-quarters of 
the patients (76.3%) were aged 40 years or less. The sex ratio was 1.1 male for every 
female. 
      2) Occurrence of M. pneu. pneumonia: In the number o f cases o f M. pneu. 
pneumonia and the percentage of M. pneu. pneumonia for total PAP during the period 
from 1968 to 1982 are shown in table 2. Periodic outbreaks of M. pneu. pneumonia were 
observed every three to four years. The first outbreak occurred from 1971 through 1972, 
the second from August through. November in 1975, and in periods the spring of 1976, 
and the third in the spring of 1980. In these, the percentage of M. pneu. pneumonia 
for PAP showed 40% or more. Particulary, M. pneu. pneumonia was observed in 58.4% 
of all patients with PAP in 1980. 
     3) Seasonal distribution : The seasonal occurrence in the number. of cases of M. 
pneu. pneumonia is shown in figure 1. The year was divided into four seasons (spring, 
summer, fall and winter). The peak of the number of cases was seen in 1972/73, 1975/ 
76 and 1980. 
     4) Monthly distribution (Table 3) : Monthly distribution of the patients with 241 
of M. pneu. pneumonia revealed that the highest incidences occurred in April (14.9%), 
May (12.9%) and August (12.0%), while the lowest incidences occurred in January (2.9
Table 1. Distribution of age and sex of Me pneumoniae pneumonia patients. 
 Age Male Female Total 
  0...... 5 11 5 16 
  6...... 9 8 11 19 
10......15 15 4 19 
16......19 14 10 24 
20......29 22 29 51 
30......39 24 31 55 
40......49 19 11 30 
50......59 6 7 13 
60......69 5 4 9 
70...... 2 3 5 
Total 126 115 241
Table 2. The yearly occurrence in the number of cases of M.pneuminiae pneumonia 
         and the percent of M. pneumoniae pneumonia against total primary atypical 
         pneumonia during the periods from 1968 to 1982 in Nagasaki city and its 
         suburbs.
Year Primary atypical pneumonia R . pre .m„niaA pneumonia M.pneumoniae pneumonia                                                               primary atypical pneu
monia 
1968 8 cases 3 cases 37.5 
1969 15 4 26.7 
1970 30 7 23.3 
1971 22 10 45.5 
1972 32 14 43.8 
1973 57 15 26.3 
1974 29 3 10.3 
1975 81 36 44.4 
1976 48 20 41.7 
1977 55 9 16.4 
1978 36 4 11.1 
1979 30 10 33.3 
1980 173 101 58.4 
1981 11 3 27.3 
1982 15 2 13.3 
Total 642 cases 241 cases
Figure 1. The seasonal occurrence in the number of cases of Mycoplasma pneumoniae 
        pneumonia during the periods from 1968 to 1982. Each year was devided into 
         four seasons: spring (March-May); summer (June-August); fall (Septem-
         ber-November) and winter (December-February).
       Table 3. Monthly occurrence of M. pneumoniae pneumonia during the periods 
               from 1968 through 1982 
      Jan. Feb. Mar. Apr. May. Jun. Jul. Aug. Sep. Oct. Nov. Dec. Total 
1968 1 1 1 3 
1969 1 1 1 1 4 
1970 5 1 1 7 
1971 1 2 2 2 1 1 1 10 
1972 1 1 2 2 2 1 3 2 14 
1973 1 1 5 2 2 1 1 2 15 
1974 1 1 1 3 
1975 3 2 1 1 1 9 6 5 5 3 36 
1676 1 2 3 3 3 2 1 1 3 1 20 
1977 2 2 4 1 9 
1978 1 2 1 4 
1979 1 1 1 1 1 2 1 2 10 
1980 1 8 19 16 19 10 15 7 2 2 2 101 
1981 1 1 1 3 
1982 1 1 2 
Total 7 13 27 36 31 23 22 29 14 13 14 12 241
%) and December (5.0%). A tendency for a low prevalence was observed in the witer 
season. As shown in Figue 2, a difference in patterns of seasonal incidence was 
observed between 1975 and 1980, showing that the peak was observed from late summer 
through fall in 1975, whereas it was observed in spring in 1980. 
     5) CF titer in all patients with acute respiratory disease (Figure 3) : The highest 
titer of the CF antibody in 2754 patients with acute respiratory diseases tested during a 
15-year peroid revealed high values in 1971/72, 1975/76 and 1980, paralleling with high 
incidence o f M. pneu. pneumonia. 
    
. 6) Isolation of M. pneumoniae : Specimens taken from 154 patients with M. pneu. 
pneumonia were cultured from M. pneu. pneumonia. Of these, M. pneu. was isolated 
from upper respiratory tract in 80 cases (51.9%). 
     7) Clinical manifestations : The clinical signs and symptoms of patients with M. 
pneu. pneumonia at the initial examination are shown in table 4. All patients produced 
a characteristic cough, which was particularly severe at night and some patients had 
persisting cough for 3 to 4 weeks, even after the resolution of abnormal roentgenographic 
findings. Fever (~37°C) was present 220 patients (93.6%) ; 32.8% of them had fever 
greater than 39°C, and 68.9% had fever of 38°C. Of the patients, sputum was ejected 
in 73.6% dry or moist rales were found in 60.4%, headache developed in 54.3%, and 
chest pain was present in 22.0%. Although myringitis has been reported to be aassociated 
with M. pneu. pneumonia in children, it was present in only 6 cases. Skin rash was a 
complicated in 5 patients. Thus, the salient features o f M. pneu. pneumonia in the pre-
sent study were persistent cough, sputum ejection, fever and headache, whereas symptoms 
such as nasal symptoms, chest discomfort and sore throat were relatively low incidence.
Figure 2. Monthly incidence of M. pneumoniae pneumonia in 1975 and 1980
Figure 3. Percentage of CF antibodies titer against Mycoplasma pneumoniae of acute 
          respiratory diseases patients in Nagasaki city and its suburbs. 
          a( ): the number of acute respiratory disease patients in each year.
     8) Laboratory findings : Laboratory data revealed that leucocyte count remained 
within the normal limits in almost all cases, but some patients showed remarkable leu-
cocytosis. Sedimentation rate increased moderately and C-reactive protein was positive 
in about 85% of all cases. The cold hemoagglutinin titers of 64 fold or more were 
detected in 53.6% of 224 cases of M. pneu. pneumonia, whereas in 43.0% of 249 cases 
with PAP (Table 5). Impairement of liver function was noted in 27 (20.6%) out of 131 
patients examined.
         Table 4. Clinical symptoms and findings in M. pneumoniae pneumonia patients. 
                     No. of patients investigated positive cases percent of positive cases 
Cough 241 241 100.0 
Sputum 231 170 73.6 
Sore throat 238 78 32.8 
Coryzal symptom 239 37 15.5 
Chest pain 236 52 22.0 
Fever 235 220 93.6 
         36.0••• 15 6.4
         37.0... 58 24.7
         38.0••• 85 36.2
        39.0--- 67 28.5
         40.0••• 10 4.3
Headache 232 126 54.3 
Digestive disorder 125 16 12.8 
Arthralgia 220 14 6.4 
Skin rash ? 5 ? 
Otalgia ? 6 ? 
Rales 235 142 60.4 
Liver function disorder 131 27 20.6
    Table 5. Distribution of cold hemoagglutinin titers in M. pneumoniae pneumonia 
              and primary atypical pneumonia at initial examination. 
Cold hemoagglutinin titer Me pneumoniae positive Me pneumoniae negative 
                          (cases) (%) (cases) (%)
       ......2048 x 3 1.3 2 0 .8 
        1024 10 4.5 4 1.6 
         512 29 12.9 10 4.0
         256 23 10.3 22 8.8
         128 34 15.2 39 15.7
          64 21 9.4 30 12.0
         32 21 9.4 27 10.8
          16 14 6.3 18 7.2
          8 15 6.7 33 13.3
               4•••••• 54 24.1 64 25.7
       Total 224 cases 249 cases
     9) Roentgenographic findings : The shadows were most commonly observed in the 
lower field, followed in order by the right lower field, the left lower field, and the 
middle lower field. Frontal and lateral chest X-ray revealed preferential occurrence of 
the lesion in the segments of S4, S5, S8 and S10 of the right lung and mainly around in 
the segments of S3, S'° of the left lung. Forty-three cases (17.8%) had bilateral abnor-
malities. The BROLIN's classification') of disease was used to evaluate the chest X-ray 
patterns in the present study group. Of patients studied at the first examination, 54% 
showed an alveolar pattern, 9% an interstitial pattern and 30% had a mixed alveolar an 
interstitial pattern of initial examination. Pleural effusion was developed in 11 patients 
(4.6%) and atelectatic changes was observed in 3 patients. 
                    DISCUSSION 
     M. pneu. infections commonly occures in children and young adults'). M. pneu. 
pneumonia has been reported to account for 10 to 40% of all cases of PAP"). This 
wide deviation in the incidence o f M. pneu. pneumonia is attributed to differences in 
age and life style of the patients surveyed and variations in prevalence. 
     In the present study, I examined 241 patients (37.5%) ranging in age from 10 
months to 84 years with M. pneu. pneumonia among 642 cases of PAP encountered over 
the past 15 years. During this time periodic epidemic peaks were noted every 3 to 5 
years. Each epidemic period continued for 6 to 8 months. These epidemic peaks were 
also noted by LIND23)24), PONKA3o)31) and NIITSU28). Seasonal prevalence was diffe-
rence for each epidemic year with a slight tendency towards decrease in the months 
from October to February. As to age, a large proportion of the patients were less than 
40 years old in the present study. On the other hand, the incidence was low in patients 
aged above 50 years. The youngest patient was a 10-month-old male and the oldest an 
84-year-old female. 
     Various studies have been carried out on the occurrence of M. pneu. infections in 
Europe (Figure 4). LIND22)23)24) reported their results for a 17-years study from 1958 
through 1974, by which sera were supplied by a central serological laboratory. All sam-
ples were examined for cold agglutinins and M. pneu. antibody titer. It was reported 
that four epidemics had occurred at regular four and a half year intervals. There were 
four epidemic peaks in 1958/59, 1962/63, 1967/68 and 1971/72. 
     In England, NOAH29) carried out a 9-year study, from 1967 through 1975, at the 
Epidemiological Research Laboratory o f the Public Health Laboratory Service. They ob-
served outbreaks o f M. pneu. infections in 1971/72 and 1974/75. There was also moderate 
of a peak in 1967/68, indicating a probable epidemic. These epidemics occurred every 
3 to 5 years. 
     In the Netherlands, HERS") carried out a 6-year study from 1961 through 1966. 
He detected M. pneu. infections in 256 (41.2%) out of 622 patients with respiratory tract 
infections. The outbreaks occurred every 4 years, in 1961/62 and 1965/66.
Figure 4. The data presented represents the number of cases of primary atypical pneu-
         monia reported or the percent of cases with acute respiratory disease due to 
         M. pneumoniae. Diagnosis was made primarily by serologic guidance. Data 
         obtained from the following references: Norway No. 1 (30), Sweden No. 2 
        (30), Finland No. 3 (16), Finland No. 4 (30), Denmark No. 5 (24, 30),
        United Kingdom No. 6 (29) and The Netherlands No. 7 (15).
     JANSSON10 reported a 9-year study in Finland from 1962 through 1970, in which 
he had 146 cases of M. pneu. pneumonia. During this period, three epidemic waves 
had developed in 1962, 1963/64 and 1967/68. Also in Finland, PONKA30) performed 
an 8-year study from 1970 through 1977, and identified 4114 cases of M. pneu. infec-
tion. There were two peak waves of outbreak during this period, in 1972/73 and in 
1977. The interval between these two epidemics was about 5 years. Epidemics were 
seen in other Scandinavian countries 1971/72,1974/75 and 1977 in Sweden, 1974/75 and 
1977 in Denmark and 1975/76 and 1977 in Norway. 
     According to these reports, there were some basic similarities in the patterns of 
the outbreaks of M. pneu. infections in these European countries. Longitudinal studies
on the occurrence of M. pneu. infections were carried out in both Denmark and Finland , 
and it was shown that there were simultaneous epidemics in 1962/63, 1967/68, 1971/72 
and 1977. Sweden had peak waves in 1971/72 and 1974/75 and Norway had outbreaks 
in 1975/76 and 1977. Thus, the Scandinavian countries experienced epidemics in practically 
in the same years. In England and the Netherlands, as well, the peak incidences of 
M. pneu. infections occurred in almost the same years as in the Scandinavian countries. 
     With regard to the periodicity of the M. pneu. infection epidemics, L1ND22)23)24) 
noted a four and a half year interval between the peaks of the waves, NOAH 29) a 3-4 
years interval, and JANSSON16) a 5-year interval. 
     Survey data are also available from the United States (Figure 5). 
     EVANS,7) carried out a 13-year study from 1953 to 1965 in Wisconsin. Evans 
studied 2549 students with acute lower respiratory tract infections of the incidence of M. 
pneu. infections. Three hundreds and seventy-eight were diagnosed to have.M. pneu. 
infections, indicating that epidemics occurred in 1954/55, 1960/61 and 1964/65, showing 
to be 4-5 years. MONTO26) carried out a 6-year study o f 3243 cases o f respiratory in-
Figure 5. The data presented represents the number of cases of primary atypical pneu-
         monia reported or the percent of cases with acute respiratory disease due to 
         M. pneumoniae. Diagnosis was made primarily by serologic evidence. Data 
        obained from the following references: Wisconsin No. 1 (7), Michigan No. 
        2(26), New York No. 3 (3), Washington State No. 4 (12), North Carolina
        No. 5 (8) and Louisiana No. 6 (27)
fections in Michigan between 1966 and 1971. M. pneu. infections were identified in 172 
of these patients. Outbreaks of M. pneu. infections occurred in 1968/69 and 1970. 
      CHANOCK3) studied the incidence of M. pneu. infections in Marine recruits 
durnig the 7-year-period from 1959 through 1965. The results indicated that 38% of 1369 
cases of pneumonia were M. pneu. infections. Epidemics occurred in 1959/60 and 1965. 
      A epidemic survey of M. pneu. infections was carried out by FOY12> in Washington 
State between 1963 and 1975. A total o f 15,141 cases o f pneumonia was investigated, and 
13% of these were found to be positive for M. pneu. infection. During this period, two 
outbreaks occurred in 1967 and 1974. 
      MOGABGAB27) carried out a 7-year survey from 1959 through 1966, of young 
airmen at a Mississippi Air Force base. This study revealed outbreaks in the years 1960/ 
61 and 1965. 
      According to these data in the United States, it was suggested that M. pneu. in-
fections were occurred with a intervals of 3 to 5 years for the period from 1953 through 
1975. 
      In Japan, KITAMOTO 19,20) carried out a 6-year survey from 1963 through 1968 
in Tokyo (Figure 6). A total of 235 cases of M. pneu. pneumonia were found among 639 
cases o f PAP showing an incidence o f 37%, A comparison study o f the incidences for 
each year revealed outbreaks of M. pneu. infections in 1964 and 1968 with the interval 
of 4 years. 
      NIITSU28> made a 21-year survey in Sendai City, extending from 1960 through 
1980. They carried out tests for M. pneu. infections which were diagnosed as having 
pneumonia based on the results o f chest X-ray in mass medical examination o f school 
children. The data revealed epidemics in the years of 1964, 1968, 1972, 1976 and 1980, 
which means that a peak of M. pneu. infection occurred at regular intervals of 4 years, 
showing beautiful cyclic patterns in Sendai. 
     The present study was carried out in Nagasaki City and its suburbs during the 15-
year period from 1968 through 1982. 
     The results of the survey indicated that the percentage of patients found to be 
positive for CF antibody titer for M. pneu. and the number of patients diagnosed for M. 
pneu. pneumonia showed peaks in 1971/72, 1975/76 and 1980. Seasonal epidemic peaks 
occurred in 1972/73, 1975/76 and 1980. 
     Thus, M. pneu. infections showed a cyclic pattern of recurrence of about 3 to 5 
years in Nagasaki area. A comparison among the three Japanese cities of Sendai, Tokyo 
and Nagasaki shows that both Sendai and Tokyo had epidemics in 1964 and 1968, whereas 
both Nagasaki and Sendai had outbreaks in 1972, 1976 and 1980. 
     M. pneu. infections have monthly been reported in fall and winter, but may also 
occur at other seasons31). In the present study, a comparison of the number of cases of 
M. pneu. infections and monthly occurrence shows that the greatest number of infections 
occurred in April and August, whereas the fewest were recored in the winter. How-
ever, different patterns were observed in monthly incidence among each epidemic year.
Figure 6. The data presented represents the number of cases of primary atypical pneu-
         monia reported, the rate per 10,000 population or the percent of cases with 
         acute respiratory disease due to M. pneumoniae. Data obtained from the
        following references: Sendai No. 1(28), Tokyo No. 2(20) and Nagasaki by 
          author's.
The peaks of occurrence were observed in August, September and October in the epide-
mic year of 1975, but in March, April, May, June and July in 1980 (Figure 2). 
     On the other hand, POMKA3°)31) found a large number of M. pneu. infections in 
the months of October, November and December, but few in June, July and August. 
EVANS7) detected peaks in September and October, and continuing into November and 
December. 
     EDWARDS6> reported that, as a result of averaging the data obtained for a 5-year 
period, the smallest number of cases of M. pneu. infections was seen in May, while 
peaks occurred in September and November. 
     LIND22> reported that outbreaks occurred in the three months of October, Novem-
ber and December.
     GRAYSTONI4) reported that M. pneu. infections increased in the winter and spring, 
whereas FRANSEN13) detected many cases from fall to winter. 
     FoY12) and MONTO26), on the other hand, reported no seasonal characteristics in 
the number of cases of M. pneu. infections. 
     With regard to extensive epidemics, M. pneu. infections are very prolonged, lasting 
for months at least a few months. My data also showed that the epidemics in 1975 and 
1980 extended for 5 to 6 months. These prolonged epidemic is understandable in view 
of the long incubation period of the disease' 5)21)29) and the prolonged carriage of M. 
pneu. in the infected patient. 
     As for regional defferences in M. pneu. infection epidemics, KRENCH21) divided 
Switzerland into central, eastern and western sections, and investigated the changes in 
the population bearing antibodies against M. pneu.. He noted that an epidemic occurred 
in the central region in 1965, and in the eastern section in 1966. He thus found that 
there was a slight difference in the time of epidemics among the regions of Switzerland. 
     TAKESHITA33> also reported that there were considerable differences of the dis-
tribution of CF antibodies titer for M. pneu. among the three areas of Nagasaki, Ohmura 
and Sasebo in Nagasaki Prefecture. 
     Therefore, differences are seen in timing of occurrence of M. pneu. epidemics, 
even among these closely-situated areas. These findings indicate that M. pneu. epidemics 
represent minor epidemics in small areas, rather than an epidemic rapidly spreading over 
wide regions at the same time. Also the outbreak of M. pneu. infections and the dis-
tributions of antibody titer in the population discloses that the waves of outbreaks of M. 
pneu. infections were not seen over the world at the same season. Furthermore, the 
individual sensitivity to M. pneu. and the presence of protective antibodies against M. 
pneu. appear to be important factors in the occurrence of M. pneu. epidemics and the 
development of disease. 
     According to STEINBERG32), the environment of a military platoon is optimal for 
the development of an M. pneu. epidemic, and such a closed and small environment 
were seems to be a key to factor to support an epidemic. STEINBERG32> also reported 
that the presence of antibodies for M. pneu. influenced the spread of the epidemic. 
     MACCORMICK25) carried out a detailed study with regard to the relationship between 
M. pneu. epidemics and pre-existing M. pneu. antibodies in the military. The results 
showed a clear relationship between the presence o f an antibody titer o f 1 :16 or more 
and the development of "mild infection" or "serious pneumonia". 
      The occurrence of an epidemic of M. pneu. infection is dependent on the presence 
o f antibodies against M. pneu. in the general population. It is thought that the next 
outbreaks in some regions will be begin the year when the titer of acquired antibody 
from the last epidemic gradually decreased. The interval between the peak of the waves 
of M. pneu. infections shows cyclic variation. It has been posturated that the seasons 
for these long cyclic intervals is a long incubation period')"), or a low communicability 
in the infection of M. pneu.24~. Most reports have shown an interval of 4 to 4.5 years,
but it would seem reasonable to assume an interval within the range of 3 to 5 years. 
     In the present study, 642 cases with PAP were examined over the past 15 years. 
The percentage o f M. pneu. pneumonia for PAP is 37.5%. Three epidemic waves o f 
M. pneu. infection were seen in Nagasaki city during and surrounding suburbs during 
1968 to 1982. 
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